Treace Medical Concepts (TMCI) Projects 2026 Revenue Between $206M and $210M
Treace Medical Concepts (TMCI) reported strong third-quarter performance, characterized by double-digit growth in case volumes and consistent market share gains. CEO John Treace expressed optimism regarding the company's trajectory, noting that current momentum is driving a narrowing of full-year guidance. Looking toward long-term growth, the company has outlined an ambitious expansion strategy targeting a $700 million Total Addressable Market (TAM). This strategic focus aims to leverage recent volume successes to capture a larger portion of the medical device sector.
Tickers: $TMCI